机译:Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Department of Surgery & Cancer, Imperial College London,Hammersmith Hospital;
Division of Gastroenterology & Hepatology, Department of Internal Medicine III,Medical University;
Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute,Mount Sinai HospitalSema4Division of Medical Oncology, Department of Medicine,Kansas University Cancer CenterDivision of Hematology/Oncology,East Carolina UniversitySection of Gastroenterology,Hepatology & Nutrition, the University of Chicago MedicineDepartment of Gastroenterology, Hepatology & Nutrition,The University of Texas MD Anderson CancerDivision of Hematology and Oncology,Weill Cornell Medicine/New York Presbyterian HospitalDivision of Gastroenterology and Hepatology, Department of Medicine,Taipei Veterans General HospitalDepartment of Medicine II, Faculty of Medicine,Medical Center University of Freiburg, University ofDepartment of Gastrointestinal Medical Oncology,The University of Texas MD Anderson Cancer CenterMedical Oncology and Hematology Unit, Humanitas Cancer Center,IRCCS Humanitas Research HospitalDepartment of Biomedical Sciences,Humanitas UniversityDepartment of Gastroenterology and Hepatology,Kindai University Faculty of Medicine1st Department of Internal Medicine, Gastroenterology and Hepatology,University Medical Center ofDepartment of Gastroenterology, Hepatology and Endocrinology,Hannover Medical School;